Abstract
Drug persistence is a phenomenon by which a small percentage of cancer cells survive the presentation of targeted therapy by transitioning to a quiescent state. Eventually some of these persister cells can transition back to an active growing state and give rise to resistant tumors. Here we introduce a quantitative genetics approach to drug-exposed populations of cancer cells in order to interpret recent experimental data regarding inheritance of persister probability. Our results indicate that alternating periods of drug treatment and drug removal may not be an effective strategy for eliminating persisters.
Original language | English |
---|---|
Article number | 108101 |
Journal | Physical Review Letters |
Volume | 129 |
Issue number | 10 |
DOIs | |
State | Published - 2 Sep 2022 |
Bibliographical note
Publisher Copyright:© 2022 American Physical Society.
Funding
D. A. K. acknowledges the support of the U.S.-Israel Binational Science Foundation, Grant No. 2015619. H. L. acknowledges the support of the NSF, Grants No. PHY-1935762 and No. PHY-2019745. We acknowledge useful conversations with Ravid Sraussman and Adi Berger.
Funders | Funder number |
---|---|
National Science Foundation | PHY-1935762, PHY-2019745 |
United States-Israel Binational Science Foundation | 2015619 |